GA2-11567-90715
3 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 752 / TX
- Registered
- 2022-09-22
- Relationship
- Child or adolescent in my care
- Guardian
- 2LH-14921-98030
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-05
Dose 1 — Pfizer-BioNTech
-
2021-11-27
Dose 2 — Pfizer-BioNTech
-
2022-06-15
Dose 3 — Pfizer-BioNTech
-
2022-09-22
Registered in v-safe
-
2022-12-16
Survey response — 6 months, dose 3, dependentMedDRA: Blood pressure increased, Dizziness, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: High blood pressure levels. Dizziness and severe vertigo.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-05 | Pfizer-BioNTech | No |
| 2 | 2021-11-27 | Pfizer-BioNTech | No |
| 3 | 2022-06-15 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: High blood pressure levels. Dizziness and severe vertigo.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure increased | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release